{
  "compound": "Medical cannabis (various)",
  "condition": "PTSD",
  "effect_size": "Large (75% symptom reduction)",
  "study_type": "OBSERVATIONAL",
  "source": "NORML:PTSD_OBSERVATIONAL_001",
  "participants": "404 PTSD patients in medical cannabis program",
  "year": 2018,
  "notes": "Medical Cannabis and PTSD: Large Prospective Registry Study",
  "confidence": "medium",
  "abstract": "75% reduction in PTSD symptoms at 12 months; PCL-5 mean reduction of 28 points; 63% no longer met criteria"
}